Skip to content

Ayurvedic management of skin disease

Evaluation of effect of agada based treatment protocol in the management of vipadika palmoplantar psoriasis an open labelled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098598
Enrollment
36
Registered
2025-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Harshita Patle
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Clinically diagnosed cases of Vipadika as per classical Ayurvedic texts 2 Patients aged between 18 to 60 years irrespective of gender 3 Diagnosed cases of Vipadika palmoplantar psoriasis who are not on any treatment since 1 month

Exclusion criteria

Exclusion criteria: 1 Chronic case of Vipadika more than five years 2 Patients with Diabetic Psoriasis vulgaris Erythrodermic pustular or generalized plaque psoriasis i e not limited to palms and soles 3 Presence of systemic illnesses 4 Pregnant or lactating women 5 Patients with known hypersensitivity or allergy to any ingredients of the Agada-based formulation or procedures

Design outcomes

Primary

MeasureTime frame
to assess the subjective parameters like pani pada sphutana kandu daha pidika vedana raga To assess the impact of Agada based treatment protocol on patient daily life and wellbeing by using Dermatology Life Quality Index DLQI and photographic documentationTimepoint: 0th 15th 30th 45th

Secondary

MeasureTime frame
to assess objective parameter using m PPPASI scoreTimepoint: 0th 15th 30th 45th

Countries

India

Contacts

Public ContactDr Rudramma R Hiremath

KAHER Shri BMK Ayurveda Mahavidyalaya Shahapur Belgaum 590003 Karnataka India

hemalata.kaher@kleayurworld.edu.in9480539098

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026